Skip to main content

ADVERTISEMENT

Asher Chanan-Khan, MD

Asher Chanan-Khan, MD
Conference Coverage
01/29/2024
At the Lymphoma, Leukemia & Myeloma Congress, Asher Chanan-Khan, MD, argued in favor of treatments targeting BCL-2 for patients with chronic lymphocytic leukemia (CLL). 
At the Lymphoma, Leukemia & Myeloma Congress, Asher Chanan-Khan, MD, argued in favor of treatments targeting BCL-2 for patients with chronic lymphocytic leukemia (CLL). 
At the Lymphoma, Leukemia &...
01/29/2024
Oncology